The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy.
Carmen Beatriz VisioliAnna IossaGiuseppe GoriniPaola MantelliniLisa LelliNoemi AuzziCarmelina Di PierroFrancesca Maria CarozziMarco ZappaPublished in: Journal of medical screening (2023)
Human papillomavirus testing can identify women at increased risk of recurrence and this supports a recommendation for its use in the post-treatment follow-up of cervical intraepithelial neoplasia, grade 2/3 lesions.